Blueprint Medicines Corporation announced that the U.S. Food and Dru Administration (FDA) has approved AYVAKIT (avapritinib) for the treatment of adults with indolent systemic mastocytosis (ISM)....
BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, announced that it will continue clinical validation of a novel...
The Lupus Foundation of America (LFA) launched the rebranded Be Fierce.Take Control. campaign during Lupus Awareness Month with rebranded imagery to connect with young Black/African American and Hispanic/Latina Women at greater risk of developing...
Mobile health (m-Health) has been heralded as the most innovative and enabling area for global digital healthcare transformation for nearly two decades. However, with...
